Orphan Drugs 2025 _ Event Postponement

This is to inform that due to some circumstances beyond the organizer control, “2nd International Conference on Orphan Drugs and Rare Diseases” (ORPHAN DRUGS 2025) scheduled during March 13-15, 2025 in Rome, Italy has been postponed. The updated dates and venue will be displayed shortly.

Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.

For further details, please contact us at orphan-drugs@magnusconference.com or call + 1 (702) 988 2320.

HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

2nd International Conference on Orphan Drugs and Rare Diseases

March 13-15, 2025

March 13 -15, 2025 | Rome, Italy
Orphan Drugs 2025

Harsha Rajasimha

Speaker at Rare Diseases Conference
Harsha Rajasimha
Jeeva Clinical Trials, Inc, United States

Biography:

Dr. Harsha Karur Rajasimha is a healthcare and life sciences scientist, social entrepreneur, and the CEO of Jeeva Clinical Trials. He earned his PhD in Genetics, Bioinformatics and Computational Biology at Virginia Tech (2007). He also founded the Indo US Organization for Rare Diseases, focused on advancing research and advocacy for rare diseases. Dr. Rajasimha received the Sanofi Genzyme’s rare diseases Patient Advocacy Leadership award in 2016. An accomplished scientist, Dr. Rajasimha has over 16 years work experience and 15 peer-reviewed publications, book chapters, and is often invited speaker including keynote addresses at international conferences.

2025
Keynote Presentation (Virtual)
Title : Emerging solutions for inclusive orphan drug clinical trials management
2023
Keynote Presentation
Title : What does a technology-enabled patient concierge mean to the orphan drugs industry?

Quick Links

Watsapp
a